"There is great interest and anticipation around the President’s call for the development and implementation of a National HIV Strategy. The three main priorities of this plan include: 1) reducing HIV incidence; 2) improving access to care and optimizing health outcomes for people infected with HIV; and 3) reducing HIV-related health disparities. During the Atlanta conference, Jeff Crowley, the director of the White House Office of National AIDS Policy, spoke of the community forums his office is conducting in 14 U.S. cities most affected by HIV/AIDS to solicit public input on how to form this national strategy"Read more in AIDS. Full story...
"Shortly after his diagnosis, however, his insurance company, Fortis [now known as Assurant Health], revoked his policy.
"Adding cyclosporine to an antiretroviral (ARV) regimen during the first few weeks or months of HIV infection does not offer additional benefit in terms of virus suppression, CD4 cell increases or reduced immune activation.
"This finding may help to develop effective ART regimens for the simian AIDS model entirely based on drugs adopted for treatment in humans.
"Conclusion: Prematurely aged (shortened) telomeres appears to be a common feature of iPS cells created by current pluripotency protocols.
"Research results to date indicate that Vacc-C5 may induce a protective
antibody response in HIV patients similar to that found in patients with a very
slow or non-progressing disease.
"A chemical in bananas has been found to inhibit HIV, according to research findings from a University of Michigan Medical School published in the March 19 issue of the Journal of Biological Chemistry.
"HIV has a hugely disproportionate impact on gay and other men who have sex with men in the US, according to new figures released by the US Centers for Disease Control and Surveillance (CDC).
"SUMMARY: HIV can hide in the bone marrow inside hematopoietic progenitor stem cells, even in people with long-term undetectable plasma viral load, according to study results reported in the March 7, 2010 online edition of Nature Medicine.
"Though this year’s Conference on Retroviruses and Opportunistic Infections (CROI) won’t likely be remembered for HIV prevention or treatment breakthroughs—there weren’t any—it certainly confirmed that research into the virus and its complications continues at a dizzying clip.
"In conclusion, Wever’s group writes, 'improvements in renal function after tenofovir cessation is variable and incomplete, particularly in patients with more gradual decline in GFR who are not receiving a protease inhibitor.
Have your say - be the first to comment
Login